The largest database of trusted experimental protocols

16 protocols using hepg2

1

Culturing and Analyzing Human Hepatocellular Carcinoma and Primary Hepatocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human hepatocellular carcinoma cell line (HepG2, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ), Braunschweig, Germany, N°ACC 180) was cultured in 25 cm2 flasks (for respiration assays) or 96-well plates (for determination of cellular ATP content and mitochondrial membrane potential) in RPMI 1640 culture medium containing 10% heat-inactivated fetal calf serum (FCS), 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 2 mM L-glutamine, 100 units/mL penicillin, and 100 mg/mL streptomycin at 37°C in a humid atmosphere (5% CO2, 95% air). Cells were passaged upon reaching confluence.
The primary human hepatocytes were kindly provided by D. Stroka (University of Bern). Primary human hepatocytes were isolated from wedges of resected liver tissues taken from patients undergoing liver surgery. Written informed consent was obtained prior to surgery in compliance with the local ethical committee [27 (link)]. Cultures from 8 donors were prepared and cultured according to Rencurel et al. [28 (link)]. Additional primary human hepatocytes (5 donors) were purchased from ScienCell Research Laboratories (Carlsbad, CA, USA) and incubated with LPS and cell viability and respiration rates of intact cells were analyzed.
+ Open protocol
+ Expand
2

Evaluating HepG2 Cell Viability in Inflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hepatoma cell line (HepG2) was obtained from Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ), Germany and grown in Roswell Park Memorial Institute (RPMI) medium supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin. Cells were seeded onto microtiter plates (96-wells) at 4.4 × 103 cells/0.5 cm2 well and incubated for four days. Every two days, the medium was changed and on day five the medium was removed and cells were incubated with the following substances at different concentrations: LPS (3.125-50 μg/ml), TNF-α (5-40 ng/ml), rolipram (5-40 μM), LPS + rolipram, and TNF-α + rolipram. As a reference, each plate contained cells incubated with control solution consisting of the medium with maximum volume of solvents contained in the test reagents (H2O or H2O plus dimethyl sulfoxide). After 21 hours of incubation time, cell viability was determined with EZ4U-tests (dye XTT, Biomedica GmbH and Co. KG, Austria) carried out as previously described.[21 (link)22 (link)] In a subsequent set of experiments, cell viability was assessed for HepG2 cells after HO-1 inhibition by chromium mesoporphyrin (CrMP; Frontier Scientific, Utah, USA) in the inflammatory milieu of TNF-α, LPS, and rolipram alone as described above.
+ Open protocol
+ Expand
3

Culturing HepG2 and MCF-7ΔAHR Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human hepatoma cell line HepG2 was purchased from DSMZ (Braunschweig, Germany). HepG2 cells were grown in RPMI 1640. MCF-7∆AHR cells were cultured in DMEM. Both cell lines were maintained in 5% CO2 at 37 °C in culture medium containing 10% (v/v) FCS, 100 U/ml penicillin, 100 mg/ml streptomycin, and 2 mM L-glutamine. All media components were purchased from Pan-Biotech (Aidenbach, Germany). AHR-deficient variant of MCF-7 cells were kindly provided by Dr. P. Tarnow37 (link).
+ Open protocol
+ Expand
4

HCC Cell Culture and Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCC cells Huh7 and HepG2 were obtained from DSMZ (Braunschweig, Germany), maintained in complete cell culture medium (DMEM medium, 10% FBS, 100 mg/ml streptomycin and 100 U/ml penicillin) and cultured in humidified atmosphere at 37°C with 5% CO2. PP7080 shRNA (#1 forward: CAGGAGGAGTTCTTAAAGAG and #2 forward:TTTGGGATTCAGTGGTTATTC), miR-601inh or SIRT1 overexpression plasmid was transfected into HEK293T cell by Lipofectamine® 3000.
+ Open protocol
+ Expand
5

Cell Culture Conditions for Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human breast cancer cell lines MCF-7, SK-BR-3 and MBA-MB-231 (triple-negative), LNCap (human prostate carcinoma lymph node metastasis), HeLa (cervix carcinoma), HepG2 (hepatocellular carcinoma), and HCT116 (human colon carcinoma) were purchased commercially from DSMZ (Braunschweig, Germany). If not otherwise stated, all cell culture media and supplements were obtained from Life Technologies (Darmstadt, Germany).
Cells were cultured as described previously [36 (link)]. In detail, MCF-7 in RPMI medium containing 10% fetal bovine serum (FBS), 1 mM sodium pyruvate, and 0.1 M nonessential amino acids (NEAA); HeLa and HepG2 in RPMI medium containing 10% FBS and 2 mM Glutamax; MDA-MB-231 in Leibovitz’s L15 with 10% FBS; HCT116 and SK-BR-3 in McCoy’s 5A medium containing 10% FBS and 2 mM Glutamax; and LNCap in RPMI medium containing 10% FBS, 1 mM sodium pyruvate, 0.1 M NEAA, 2 mM Glutamax, and 0.01 M HEPES. All cell culture media were used without antibiotics. MCF-7, HCT116, SK-BR-3, LNCap, HeLa, and HepG2 were maintained at 37 °C in a humidified incubator with a 5% CO2 atmosphere and MDA-MB-231 cells were handled without gaseous exchange. The absence of mycoplasma in the cell culture was regularly tested using the Venor GeM qOneStep-Kit (Minerva-biolabs, Berlin, Germany).
+ Open protocol
+ Expand
6

Genotoxicity evaluation of lignans

Check if the same lab product or an alternative is used in the 5 most similar protocols
All chemicals and solvents used in this work were of analytical grade or compliant with standards required for cell culture experiments. Formamidopyrimidine glycosylase (FPG) was kindly provided by Prof. Andrew Collins (University of Oslo, Norway).
Syringaresinol (4,4′-(1S,3aR,4S,6aR)-Tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diylbis(2,6-dimethoxy-phenol); Syr) was purchased from BOC Science (NewYork, USA). Enterodiol ((2R,3R)-2,3-bis[(3-hydroxyphenyl)methyl]butane-1,4-diol; END), enterolactone ((3R,4R)-3,4-bis[(3-hydroxyphenyl) methyl]oxolan-2-one; ENL), dimethyl sulfoxide (DMSO) 99,6%, sodium dodecylsulfate (SDS), absolute ethanol (≥99.8%), trypan blue solution, resazurin, and ethidium bromide were obtained from Sigma-Aldrich (Munich, Germany). Low and normal melting agarose were obtained from Bio-Rad (Munich, Germany), and trypsin was obtained from Serva (Heidelberg, Germany). Cell culture media (RPMI 1640, DMEM) were purchased from Thermo Fisher Scientific (Dreieich, Germany) while the supplements fetal calf serum (FCS) and penicillin/streptomycin (P/S) were obtained from Invitrogen (Karlsruhe, Germany). Cell culture materials (petri dishes, flasks, etc.) were acquired from Greiner Bio-One (Essen, Germany). The cell lines HepG2 and HT29 were purchased from DSMZ (Braunschweig, Germany).
+ Open protocol
+ Expand
7

Sorafenib and Perhexiline Inhibit HepG2 Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hepatocellular carcinoma cell line HepG2 was obtained from DSMZ (DSMZ, Braunschweig, Germany) and cultivated according to DSMZ instructions. A proliferation assay was performed using the colorimetric CellTiter 96® AQueous One Solution Cell Proliferation Assay (MTS) (Promega, Fitchburg, USA) according to instructions from the manufacturer. In brief, HepG2 was separately treated with 2 and 4 μM of sorafenib (Santa Cruz Biotechnology, Inc., Dallas, USA) and with 2, 4, 8, and 20 μM of perhexiline maleate salt (Sigma‐Aldrich, St. Louis, USA) for 24 and 48 h. Both compounds were dissolved in DMSO, and corresponding concentrations of DMSO in the medium were used as controls. In addition, controls consisting of cells growing in only cell culture medium were included. For all concentrations of sorafenib and perhexiline maleate salt, and for corresponding DMSO controls, eight replicates were analyzed. For the controls consisting of cells in only medium, 16 replicates were analyzed. For all experiments, the measured colorimetric differences between DMSO controls and medium controls were insignificant.
+ Open protocol
+ Expand
8

Cell Line Culturing and Maintenance

Check if the same lab product or an alternative is used in the 5 most similar protocols
The chronic myeloid leukemia cell line K562 (RRID:CVCL_0004; ordered from DSMZ, Braunschweig, Germany) and BL cell line ST486 (RRID:CVCL_1712; ATCC, Manassas, VA, USA) were maintained in Roswell Park Memorial Institute 1640 medium (RPMI, Lonza, Basel, Switzerland) supplemented with 10–20% fetal bovine serum (Sigma‐Aldrich, Saint Louis, MO, USA), 2 mm l‐glutamine (Biowest, Nuaille, France), and 1% penicillin/streptomycin (Biowest) in a 5% CO2 incubator at 37 °C. Hepatocellular carcinoma cell line HepG2 (RRID:CVCL_0027; DSMZ), breast cancer cell line MCF7 (RRID:CVCL_0031; ECACC, Porton Down, UK), and HEK293T cell line (RRID:CVCL_0063; DSMZ) used for lentiviral particle production were cultured in low glucose Dulbecco's Modified Eagle's Medium (DMEM, Lonza) supplemented as described above. In addition, medium for MCF7 cells was supplemented with 1× NEAA (Gibco, Waltham, MA, USA). Cell lines were authenticated by providers in the period of 3 years before the experiments. They were expanded and banked in our laboratory immediately upon receipt. After thawing, cells were cultured for experiments no longer than 3 months. Mycoplasma tests were routinely performed and confirmed that the cells were not contaminated.
+ Open protocol
+ Expand
9

Cytokine and Inhibitor Treatment of HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HepG2 (DSMZ, Braunschweig, Germany) were grown in DMEM+F12 (Thermo Fisher Scientific) supplemented with 10 % FCS, streptomycin (100 mg/ml) and penicillin (100 mg/ml) at 37°C in a water saturated atmosphere containing 5 % CO 2 . Prior to stimulation cells were starved overnight in medium without FCS and phenol red. Cells were treated with 10 ng/ml IL-6 (Conaris, Kiel, Germany), 10 ng/ml OSM (Peprotech, Hamburg, Germany), 1 µM dexamethasone (Sigma Aldrich, St. Louis, MO, USA), 500 ng/ml insulin (Sigma Aldrich), 0.5 µM campthotecin (Sigma Aldrich), 10 µM MG-115 (Diagonal, Münster, Germany), 50 µg/ml cycloheximide (Sigma Aldrich), 4 µM actinomycin D (VWR, Darmstadt, Germany), 10 µM U0126 (Promega), 40 µM LY294002 (VWR) or 20 µM Stattic (VWR) as indicated.
+ Open protocol
+ Expand
10

Cell Culture for Cancer Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human lung (A549), breast (MCF-7), and liver (HepG2) cancer cells were obtained from German Collection of Microorganisms and Cell Cultures (Leibniz Institute DSMZ, Braunschweig, Germany). Cells were maintained at 37°C in a humidified CO 2 incubator and were cultivated in DMEM medium (Gibco, US) supplemented with an FBS (10% final concentration) and 1% penicillin and streptomycin. Cells were subcultured when they reach 70% confluency and passage number of 25-30 was maintained for bioassay.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!